Vertex Pharma (VRTX) Tops Q3 EPS by 30c; raises guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Vertex Pharma (VRTX) Tops Q3 EPS by 30c; raises guidance

Vertex (VRTX) PT Raised to $451 at RBC Capital

November 5, 2024 7:00 AM EST

RBC Capital analyst Brian Abrahams raised the price target on Vertex (NASDAQ: VRTX) to $451.00 (from $437.00) while maintaining a Sector Perform rating.

The analyst comments "CF beat and raise shows the continued health of the company's core franchise and is likely to perpetuate... More